arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

FATE THERAPEUTICS INC

FATE

$2.80 ▲ +0.31 (+12.45%) at close

19 Visible periods

30 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

FATE THERAPEUTICS INC faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $332.6M

Dividend Yield —

Revenue Growth -51.2% ↗

Op. Margin None

ROIC -56.3% ↘

FCF / Share $-0.94 ↗

Trailing P/E —

Price / Book 1.6x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

19-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$6.65M

↓ -51.2% —

Net Income Profit after all expenses

$-136.31M

↑ +26.8% —

Operating Margin Operating profit as % of sales

-299.9%

↑ +6.4% —

FCF / Share Free cash flow per share

$-0.94

↑ +13.3% —

Long-Term Debt Long-term obligations

$12.45M

↓ -16.0% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Revenue Growth YoY (%)	-51.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-741%)	-78.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1082%)	-34.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-525%)	72.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+805%)	77.7% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+871%)	194.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2329%)	125.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1466%)	15.4% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+93%)	—	—	—	—	-63.6% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-895%)	128.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1503%)	—	—	—	—	—
EPS Growth YoY (%)	29.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	43.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-29.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	26.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-15.7% Weak ↓ Weak Declining Year-over-year change in net income	42.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-32.8% Weak ↑ Weak Improving Year-over-year change in net income	-22.4% Weak ↑ Weak Improving Year-over-year change in net income	-76.7% Weak ↓ Weak Declining Year-over-year change in net income	-47.4% Weak ↓ Weak Declining Year-over-year change in net income	-55.1% Weak ↓ Weak Declining Year-over-year change in net income	-28.4% Weak ↓ Weak Declining Year-over-year change in net income	-11.6% Weak ↑ Weak Improving Year-over-year change in net income	-15.9% Weak ↑ Weak Improving Year-over-year change in net income	-23.9% Weak ↓ Weak Declining Year-over-year change in net income	-46.7% Weak ↓ Weak Declining Year-over-year change in net income	-6.0% Weak ↑ Weak Improving Year-over-year change in net income	17.2% Good ↑ Good Improving Year-over-year change in net income	-21.7% Weak Weak Year-over-year change in net income	-86.0% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	13.3% Fair ↓ Fair Declining Year-over-year change in free cash flow	22.7% Good ↑ Good Improving Year-over-year change in free cash flow	52.0% Excellent Excellent Year-over-year change in free cash flow	-30.0% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	-59.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-37.5% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	26.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	108.1% Excellent → Excellent Stable Compound annual revenue growth over 3 years	127.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	97.1% Excellent Excellent Compound annual revenue growth over 3 years	—	24.9% Excellent Excellent Compound annual revenue growth over 3 years	—	—	-3.1% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	-26.7% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	5.0% Fair ↓ Fair Declining Compound annual revenue growth over 5 years	68.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	87.9% Excellent Excellent Compound annual revenue growth over 5 years	—	66.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	—	37.3% Excellent Excellent Compound annual revenue growth over 5 years	9.0% Good Good Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Operating Margin (%) (%)	—	—	-299.9% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2099%)	-320.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2235%)	-388.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2690%)	-407.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2816%)	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	-253.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2211%)	-292.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2538%)	-379.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3266%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	-217.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-294.7% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-382.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-140.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.82x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.66x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.25x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.61x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Return on Invested Capital (%)	-56.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-52.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-40.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-50.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-25.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-26.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-32.5% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-30.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-36.2% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-29.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-36.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-41.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-26.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	21.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	20.7% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—
Return on Capital (%) (%)	-46.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-47.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-37.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-43.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-23.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-20.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-33.3% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-31.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-40.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-33.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-40.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-48.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-31.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-122.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—
Return on Common Equity (%) (%)	-65.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-539%)	-58.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-490%)	-43.7% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-391%)	-58.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-488%)	-31.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-308%)	-45.1% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-401%)	-40.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-367%)	-41.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-377%)	-55.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-471%)	-45.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-405%)	-78.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-626%)	-91.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-709%)	-41.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-374%)	27.0% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+80%)	26.5% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+77%)	43.3% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+189%)	62.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+314%)	85.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+472%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	—	0.08x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-87%)	0.19x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-68%)	0.18x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-71%)	0.57x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-5%)	0.69x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+15%)	0.03x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-94%)	-0.07x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-112%)	—	—	—	—	—
Interest Coverage (x)	—	—	—	—	—	—	-57.49x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-39.56x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-33.22x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-19.53x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-12.51x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-45.36x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-22.20x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-27.84x Weak Weak Operating income divided by interest expense Optimal: > 5x	-104.67x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—
Net Debt (USD)	$-46.63M	$-36.06M	$-41.87M	$-61.33M	$-133.58M	$-167.35M	$-99.81M	$-178.07M	$-74.14M	$-75.80M	$-43.24M	$-29.47M	$-52.29M	$-5.36M	$-6.39M	$-11.22M	—	—	—
Debt / EBITDA (x)	—	—	—	—	—	—	—	-0.19x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.36x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.41x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.80x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.80x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.10x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.29x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Revenue per Share (USD)	$0.06	$0.12	$0.65	$0.99	$0.59	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-1.15	$-1.64	$-1.64	$-2.91	$-2.24	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.94	$-1.09	$-1.41	$-2.93	$-2.25	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$1.80	$2.80	$3.74	$4.97	$7.09	$4.38	$3.23	$2.48	$1.47	$1.77	$1.32	$1.38	$2.49	$-39.60	—	—	—	—	—
Tangible Book Value per Share (USD)	$1.80	$2.80	$3.74	$4.97	$7.09	$4.38	$3.23	$2.48	$1.47	$1.77	$1.32	$1.38	$2.49	$-39.60	—	—	—	—	—
Basic Weighted Avg Shares (shares)	118.79M	113.69M	98.41M	96.83M	94.75M	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Working Capital (USD)	$172.63M	$253.39M	$292.45M	$388.02M	$552.13M	$408.76M	$199.28M	$177.93M	$91.55M	$78.14M	$52.21M	$45.29M	$50.05M	$4.94M	—	—	—	—	—
LT Debt (USD)	—	—	—	—	—	—	—	$12.45M	$14.81M	$12.81M	$21.57M	$19.63M	$1.75M	$3.73M	—	—	—	—	—
Total Equity (USD)	$207.18M	$318.73M	$368.42M	$483.94M	$678.84M	$384.44M	$244.76M	$160.47M	$77.19M	$73.15M	$38.04M	$28.34M	$50.85M	$-52.83M	$-50.68M	$-37.44M	$-21.46M	$-8.35M	$-1.22M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Sales/Revenue/Turnover (USD)	$6.65M	$13.63M	$63.53M	$96.30M	$55.85M	$31.43M	$10.68M	$4.74M	$4.11M	—	$2.43M	—	$971.00K	$2.67M	$1.17M	—	—	—	—
Depreciation Expense (USD)	$12.90M	$18.96M	$18.28M	$13.76M	$5.85M	$3.09M	$2.19M	$1.20M	$971.00K	$881.00K	$687.00K	$496.00K	$571.00K	$590.00K	$672.00K	—	—	—	—
Net Income, GAAP (USD)	$-136.31M	$-186.26M	$-160.93M	$-281.72M	$-212.15M	$-173.39M	$-98.15M	$-66.60M	$-42.95M	$-33.46M	$-29.99M	$-25.88M	$-20.89M	$-14.24M	$-13.43M	$-16.22M	$-13.33M	$-7.17M	—
Operating Cash Flow (USD)	$-106.08M	$-122.87M	$-132.26M	$-248.21M	$-162.87M	$-39.23M	$-83.17M	$-38.65M	$-36.82M	—	—	—	—	—	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 19 years · 60 quarters

FATE THERAPEUTICS INC

Analytical Summary

19-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare FATE with peers